萃華珠寶(002731.SZ):終止公司向特定對象發行A股股票事項
格隆匯12月27日丨萃華珠寶(002731.SZ)公佈,公司於2023年12月27日召開獨立董事專門會議2023年第一次會議、第六屆董事會第二次會議和第六屆監事會第二次會議審議通過了《關於終止公司向特定對象發行A股股票事項的議案》。
公司自公佈本次向特定對象發行股票方案以來,一直與相關各方積極推進相關工作,綜合考慮公司實際情況、發展規劃,並結合資本市場等諸多因素,經審慎分析後,公司決定終止本次向特定對象發行A股股票事項。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.